Findings

What do systematic reviews say?

2,539 questions · 2,602 findings · 424 reviews · Headline outcomes only

Sort:Best matchNewest Highest certainty Download CSV

No studies found 572 · 22%GRADE not reported 189 · 7.3%Very low 527 · 20.3%Low 685 · 26.3%Moderate 514 · 19.8%High 115 · 4.4%

Intervention not reported

Function (long term) WOMAC scale from 0 to 68 points (higher is worse function). · Patients with knee osteoarthritis

1 finding from 1 review

Acupuncture for peripheral joint osteoarthritis 2010 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 1398 participants
High

Intervention not reported

Pain (long term) WOMAC scale from 0 to 20 points (higher is worse pain). · Patients with peripheral joint osteoarthritis

1 finding from 1 review

Acupuncture for peripheral joint osteoarthritis 2010 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 1399 participants
High

Intervention not reported

Function (long term) WOMAC scale from 0 to 68 points (higher is worse function). · Patients with peripheral joint osteoarthritis

1 finding from 1 review

Acupuncture for peripheral joint osteoarthritis 2010 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 1398 participants
High

Intervention not reported

Pain (long term) WOMAC scale from 0 to 20 points (higher is worse pain). · Patients with knee osteoarthritis

1 finding from 1 review

Acupuncture for peripheral joint osteoarthritis 2010 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 1399 participants
High

Intervention not reported

Pain intensity various scales long‐term · adults with chronic low‐back pain

1 finding from 1 review

Behavioural treatment for chronic low‐back pain 2010 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 48 participants
Very low

Intervention not reported

Functional status (generic) Sickness Impact Profile (0‐136) long‐term · adults with chronic low‐back pain

1 finding from 1 review

Behavioural treatment for chronic low‐back pain 2010 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 51 participants
Very low

Intervention not reported

Depression Beck Depression Inventory (0‐63) long‐term · adults with chronic low‐back pain

1 finding from 1 review

Behavioural treatment for chronic low‐back pain 2010 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 51 participants
Low

Intervention not reported

Functional status (generic) various scales long‐term · adults with chronic low‐back pain

1 finding from 1 review

Behavioural treatment for chronic low‐back pain 2010 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 66 participants
Low

Summary of findings: Behavioural treatments vs other treatments

Pain intensity, long‐term · adults with chronic low‐back pain

1 finding from 1 review

Behavioural treatment for chronic low‐back pain 2010 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 136 participants
Moderate

Summary of findings: Behavioural treatments vs other treatments

Depression various scales intermediate‐term · adults with chronic low‐back pain

1 finding from 1 review

Behavioural treatment for chronic low‐back pain 2010 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 136 participants
Moderate

Summary of findings: Behavioural treatments vs other treatments

Back‐specific functional status · adults with chronic low‐back pain

1 finding from 1 review

Behavioural treatment for chronic low‐back pain 2010 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 345 participants
Low

Intervention not reported

Aggregate changes in crashes showed an insignificant 19.7% reduction in all reported crashes with a 20.1% reduction in injury crashes and an 89.8% reduction in fatal crashes along camera segments.

1 finding from 1 review

Speed cameras for the prevention of road traffic injuries and deaths 2010 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
Low

Intervention not reported

A reduction of 16% (+/‐ 7%) in expected crashes along study corridor. A 2.8km/h reduction in mean speed at monitoring site.

1 finding from 1 review

Speed cameras for the prevention of road traffic injuries and deaths 2010 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
Moderate

bed rest vs advice to stay active

Pain intensity, long‐term · Patients with acute low‐back pain

1 finding from 1 review

Advice to rest in bed versus advice to stay active for acute low‐back pain and sciatica 2010 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 393 participants
Moderate

bed rest vs advice to stay active

Functional status, long‐term · Patients with acute low‐back pain

1 finding from 1 review

Advice to rest in bed versus advice to stay active for acute low‐back pain and sciatica 2010 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 393 participants
Moderate

bed rest vs advice to stay active

Pain intensity, long‐term · patients with sciatica

1 finding from 1 review

Advice to rest in bed versus advice to stay active for acute low‐back pain and sciatica 2010 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 330 participants
Moderate

bed rest vs advice to stay active

Functional status, long‐term · patients with sciatica

1 finding from 1 review

Advice to rest in bed versus advice to stay active for acute low‐back pain and sciatica 2010 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 330 participants
Moderate

Levomepromazine vs Typical antipsychotics

Acceptability of treatment ‐ leaving the study early · patients with schizophrenia

Levomepromazine showed no clear difference in leaving the study early ‐ long term ‐ any reason compared with typical antipsychotics (moderate certainty).

1 finding from 1 review

Levomepromazine for schizophrenia 2010 · Cochrane Headline outcomes only
RR 0.4 [0.09, 1.81]
1 study · 38 participants
Moderate

Levomepromazine vs Typical antipsychotics

Leaving the study early ‐ long term ‐ due to adverse events · patients with schizophrenia

Levomepromazine showed no clear difference in leaving the study early ‐ long term ‐ due to adverse events compared with typical antipsychotics (moderate certainty).

1 finding from 1 review

Levomepromazine for schizophrenia 2010 · Cochrane Headline outcomes only
RR 1 [0.07, 14.85]
1 study · 38 participants
Moderate

Levomepromazine vs Typical antipsychotics

Leaving the study early ‐ long term ‐ lost to · patients with schizophrenia

Levomepromazine showed no clear difference in leaving the study early ‐ long term ‐ lost to compared with typical antipsychotics (moderate certainty).

1 finding from 1 review

Levomepromazine for schizophrenia 2010 · Cochrane Headline outcomes only
RR 1 [0.07, 14.85]
1 study · 38 participants
Moderate